Adolorin Ibuforte 400 mg Dragees
Recall
|
Medicines
|
30/09/2020
The marketing authorisation holder informed its customers on September 29, 2020 that a reduced release of the active substance was detected in the concerned batch.
Therefore, this batch will be recalled.
Name of the medicinal product | Adolorin Ibuforte 400 mg Dragees |
---|---|
Marketing authorisation number(s) | 1-24505 |
CIP code | 3759576 |
Marketing authorisation holder | Kwizda Pharma GmbH |
Batch number(s) | 001013 |
Classification of the recall | 2 |
Depth of recall | Pharmacies |
BASG reference number | INS-640.001-3330 |
Further inquiry note
Page last modified:
30/09/2020